‘Tis The Season… For An FDA Enforcement Letter To Alcon
This article was originally published in The Pink Sheet Daily
Executive Summary
The eighth enforcement letter from FDA in a decade cites the company for unjustified claims about its seasonal allergic rhinitis drug, Patanase.